Mark Eric Hessenthaler
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Office
- 1
Offices
1 location · Lgtc Group · 22 clinicians in this group
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Mark Eric Hessenthaler’s office at (800) 913-2615 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C154875 · Current
Licensed to practise in California · since 2018 · expires 2027-09-30 · American University of the Caribbean School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$34,975 in 2018
Medicaid paid $34,975 for 255 billed services this clinician did in 2018, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 255 | $34,975 |
| 2018 | 255 | 1 | 42 | $34,975 |
Money from drug and device companies
$528 in 2025
| 2025 | 10 | 28 | None | $528 |
| 2024 | 9 | 15 | None | $318 |
| 2023 | 7 | 28 | None | $2,100 |
| 2022 | 9 | 24 | None | $578 |
| 2021 | 5 | 12 | None | $323 |
| 2020 | 7 | 9 | None | $171 |
| 2019 | 8 | 29 | None | $530 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $177 | 11 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $70 | 3 payments
|
| Axsome Therapeutics | Auvelity | $63 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $54 | 3 payments
|
| Vanda Pharmaceuticals | Fanapt | $49 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $45 | 2 payments
|
See all 28 published payments
| Abbvie | Meals · 2025-12-12 | Vraylar | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-09 | Cobenfy | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-12-09 | Abilify Maintena | $21 |
| Bausch Health US | Meals · 2025-11-24 | Aplenzin | $20 |
| Axsome Therapeutics | Meals · 2025-10-30 | Auvelity | $33 |
| Abbvie | Meals · 2025-10-28 | Vraylar | $7 |
| Alkermes | Meals · 2025-10-28 | Aristada | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-25 | Cobenfy | $19 |
| Abbvie | Meals · 2025-09-25 | Vraylar | $27 |
| Abbvie | Meals · 2025-09-25 | Vraylar | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-23 | Caplyta | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-21 | Cobenfy | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-19 | Caplyta | $32 |
| Abbvie | Meals · 2025-08-16 | Vraylar | $13 |
| Teva Pharmaceuticals USA | Meals · 2025-07-24 | Austedo Xr | $15 |
| Axsome Therapeutics | Meals · 2025-07-22 | Auvelity | $14 |
| Abbvie | Meals · 2025-06-12 | Vraylar | $35 |
| Janssen Pharmaceuticals | Meals · 2025-06-10 | Invega Sustenna | $29 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $7 |
| Abbvie | Meals · 2025-05-01 | Vraylar | $17 |
| Vanda Pharmaceuticals | Meals · 2025-04-28 | Fanapt | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-28 | Caplyta | $19 |
| Abbvie | Meals · 2025-04-10 | Vraylar | $22 |
| Abbvie | Meals · 2025-04-09 | Vraylar | $7 |
| Janssen Pharmaceuticals | Meals · 2025-03-27 | Invega Sustenna | $16 |
| Vanda Pharmaceuticals | Meals · 2025-02-25 | Fanapt | $28 |
| Abbvie | Meals · 2025-01-28 | Vraylar | $10 |
| Axsome Therapeutics | Meals · 2025-01-28 | Auvelity | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $318
| Ironshore Pharmaceuticals | Jornay Pm | $85 | 4 payments
|
| Abbvie | Vraylar | $69 | 3 payments
|
| Axsome Therapeutics | Auvelity | $40 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Mycite | $28 | 1 payment
|
| Alkermes | Lybalvi | $27 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $23 | 1 payment
|
| Lundbeck | Rexulti | $16 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $14 | 1 payment
|
2023: $2,100
| Neuronetics | Neurostar Tms Therapy System | $1,594 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $143 | 6 payments
|
| Abbvie | Vraylar | $130 | 9 payments
|
| Alkermes | Aristada | $91 | 4 payments
|
| Iti | Caplyta | $67 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $44 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $29 | 2 payments
|
2022: $578
| Janssen Pharmaceuticals | Spravato | $98 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $97 | 4 payments
|
| Vanda Pharmaceuticals | Hetlioz | $96 | 3 payments
|
| Iti | Caplyta | $76 | 3 payments
|
| Lundbeck | Rexulti | $74 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $53 | 3 payments
|
| Corium | Azstarys | $46 | 2 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $19 | 1 payment
|
| Abbvie | Vraylar | $18 | 1 payment
|
2021: $323
| Takeda Pharmaceuticals U.S.A. | Trintellix | $116 | 5 payments
|
| Lundbeck | Rexulti | $82 | 3 payments
|
| Vanda Pharmaceuticals | Fanapt | $68 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $36 | 1 payment
|
| AbbVie | Vraylar | $21 | 1 payment
|
2020: $171
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $41 | 2 payments
|
| Allergan | Vraylar | $32 | 2 payments
|
| Vanda Pharmaceuticals | Hetlioz | $31 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $18 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $16 | 1 payment
|
| Lundbeck | Rexulti | $13 | 1 payment
|
2019: $530
| Sunovion Pharmaceuticals | Latuda | $154 | 9 payments
|
| Teva Pharmaceuticals USA | Austedo | $99 | 5 payments
|
| Shire North American Group | Vyvanse | $88 | 5 payments
|
| Lundbeck | Rexulti | $74 | 4 payments
|
| Avanir Pharmaceuticals | Nuedexta | $62 | 3 payments
|
| Janssen Pharmaceuticals | Spravato | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $18 | 1 payment
|
| Bausch Health US | Aplenzin | $11 | 1 payment
|
Professional record
- NPI
- 1487776506
- Licence
- CA C154875California C154875: Current · expires 2027-09-30
- Group
- Lgtc Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 360 Post St, Ste 500, San Francisco, CA, 94108
- NPI first listed
- 2007-04-06
- NPI last updated
- 2019-06-13
This is when the NPI record was last certified, not a medical board exam.